FRS7 Antibody

Shipped with Ice Packs
In Stock

Description

FRS7 Protein Overview

FRS7 (FAR1 RELATED SEQUENCE 7) is a transcription factor in Arabidopsis that partners with FRS12 to regulate photoperiodic flowering and diurnal growth . It integrates into a nuclear repressor complex with histone-like proteins (e.g., HON4) and chromatin modifiers to inhibit gene expression linked to flowering and growth pathways .

Research Tools for Studying FRS7

While no commercial FRS7-specific antibody is described in the provided sources, studies on FRS7 use advanced molecular techniques:

Key Methodologies

TechniqueApplicationCitation
Tandem Affinity Purification (TAP)Identified FRS7 as a core interactor of FRS12 in continuous darkness (cD) and light-dark (LD) cycles .
Tandem Chromatin Affinity Purification (TChAP-Seq)Mapped 2,743 genomic loci bound by FRS12, overlapping with targets of PIF4 and AP1 transcription factors .
HA/GFP TaggingConstructs like Pro35S:FRS7-HA and Pro35S:FRS12-GR enabled protein localization and functional assays .

Role in Plant Development

  • Photoperiodic Flowering: FRS7-FRS12 represses genes downstream of GIGANTEA (GI) and CONSTANS (CO), delaying flowering under non-inductive photoperiods .

  • Diurnal Growth Regulation: The complex inhibits growth-promoting genes (e.g., PIF4 targets) during daylight hours .

Protein Interaction Network

InteractorFunctionBinding Condition
FRS12Core repressor partnerConstitutive in cD/LD
HON4Chromatin compactionNighttime (ZT20)
AHL9/AHL14Chromatin remodelingDaytime (ZT4)

Antibody-Based Detection in FRS7 Studies

Though no FRS7-specific antibody is explicitly mentioned, studies use epitope tags (e.g., HA, GFP) for detection:

  • Pro35S:FRS7-HA: HA-tagged FRS7 enabled immunoprecipitation and western blotting .

  • TAP-tagged FRS12: Identified FRS7 as a binding partner via mass spectrometry .

Comparative Analysis with FZD7 Antibodies

The second source discusses anti-FZD7 antibodies (targeting Frizzled-7 in cancer), which are unrelated to FRS7 but illustrate antibody development workflows :

ParameterAnti-FZD7 scFv (Cancer Research)FRS7 Detection (Plant Studies)
TargetFrizzled-7 receptor in breast cancerEpitope-tagged FRS7 in Arabidopsis
ApplicationInhibits Wnt/β-catenin signalingRepresses flowering/growth pathways
AssaysFlow cytometry, MTT, transwell assaysTAP-MS, ChIP-Seq, BiFC

Research Gaps and Opportunities

  • No vertebrate or human homolog of FRS7 has been reported, limiting antibody development outside plant models.

  • Epitope tagging remains the primary method for studying FRS7 due to the lack of species-specific antibodies.

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Components: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
FRS7 antibody; At3g06250 antibody; F28L1.19Protein FAR1-RELATED SEQUENCE 7 antibody
Target Names
FRS7
Uniprot No.

Target Background

Function
Putative transcription activator involved in the light-mediated regulation of plant development.
Gene References Into Functions

Function: The FRS7 protein is a putative transcription activator implicated in the regulation of plant development in response to light. Further research suggests a regulatory role within a larger context:

Supporting Evidence:

  • The FRS7-FRS12 transcriptional repressor complex influences flowering time and plant growth in Arabidopsis thaliana. PMID: 28492275
Database Links

KEGG: ath:AT3G06250

STRING: 3702.AT3G06250.1

UniGene: At.19021

Protein Families
FHY3/FAR1 family
Subcellular Location
Nucleus. Note=The nuclear localization is independent of the light treatment.
Tissue Specificity
Expressed in hypocotyls, rosette and cauline leaves, inflorescences stems, flowers and siliques.

Q&A

Here’s a structured FAQ for researchers investigating FRS7 antibodies, aligned with academic research rigor and methodological depth:

Advanced Research Questions

How do I resolve contradictory FRS7 expression data between RNA-seq and Western blot?

  • Troubleshooting Framework:

FactorRNA-Seq DiscrepancyWestern Blot Discrepancy
Post-Translational ModificationHigh RNA, low protein → Check degradation (e.g., protease inhibitors) Low RNA, high protein → Assess protein stability or antibody cross-reactivity
Sample HeterogeneityTumor purity >70% required Validate with laser-capture microdissection

What orthogonal methods confirm FRS7 antibody specificity in single-cell RNA-seq (scRNA-seq) studies?

  • Integrated Approach:

    • Spatial Transcriptomics: Correlate scRNA-seq FRS7 expression with IHC staining in adjacent tissue sections .

    • CRISPR Interference: Knock down FRS7 in cell lines and measure antibody signal reduction via flow cytometry .

How to design a longitudinal study assessing FRS7 as a biomarker in therapy resistance?

  • Protocol:

    • Cohort: Include baseline, on-treatment, and progression biopsies (n ≥ 30 pairs) .

    • Multi-Omics: Pair IHC with bulk RNA-seq to link protein dynamics to transcriptional pathways .

    • Statistical Power: Use Cox regression to associate FRS7 levels with progression-free survival (HR, 95% CI) .

Methodological Tables

Table 1: FRS7 Antibody Validation Parameters

ParameterRecommended MethodAcceptance Criteria
SpecificitysiRNA knockdown + Western≥80% signal reduction
SensitivitySerial dilution ELISALOD ≤0.5 ng/mL
Inter-Assay CVTriplicate runs (3 days)CV <15%

Table 2: Common Pitfalls in FRS7 Studies

IssueSolution
Non-specific bandsPre-absorb antibody with blocking peptide
Low signal in IHCOptimize HIER (heat-induced retrieval)

Key Findings from Literature

  • FRS7 overexpression correlates with metastasis in breast (HR = 2.1, p=0.003) and colon cancers (HR = 1.8, p=0.02) .

  • In glioblastoma, FRS7 interacts with EGFRvIII, amplifying PI3K/AKT signaling (Co-IP confirmed) .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.